Labcorp added to its suite of tests designed to detect cancer recurrence much earlier than traditional imaging.

Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the fourth quarter of 2025 before the market opens on ...

Pixel by LabCorp ℠ Offers Self-Collected Testing Anytime, Anywhere to Empower Healthcare Consumers BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp® (NYSE: LH), a leading global life sciences company, today ...

For the full fiscal year 2025, Wall Street analysts expect Labcorp’s diluted EPS to grow by 12% annually to $16.32, followed ...

The global life sciences and health care company did not explain why it is closing the facility. The post Labcorp is closing ...

BURLINGTON, N.C.--(BUSINESS WIRE)-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that it will mark its 50th ...

Quest and Labcorp may be archrivals in the diagnostic testing market, but they appear to agree on at least one thing: the ...

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a global life sciences company, is now offering observed self-collection for COVID-19 PCR testing in more than 500 of its patient service centers ...

Labcorp Holdings Inc. LH, or Labcorp, is well-poised to grow in the coming quarters due to its strong, consistent performance in high-growth areas. In recent years, the company has built a significant ...

Lumipulse® pTau-217/Beta Amyloid 42 Ratio now available nationwide through Labcorp BURLINGTON, N.C., Aug. 18, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive ...

Strategic Collaboration Expands Patient Access to Labcorp’s Services, Drives Efficiencies and Advances Clinical Innovation The transactions build on Labcorp’s strong track record of establishing ...

NAMSA has acquired select assets of Labcorp’s early development medical device testing business, aligning with .